Tobacco Status Project: Social Media Intervention for Young Adult Smokers (TSP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02207036|
Recruitment Status : Completed
First Posted : August 1, 2014
Last Update Posted : May 8, 2017
|Condition or disease||Intervention/treatment|
|Smoking||Behavioral: Facebook intervention Behavioral: Smokefree.gov|
Participants will be randomized to one of two conditions: (1) a Facebook-delivered intervention tailored to readiness to quit smoking; or (2) the control condition (referral to the Smokefree.gov website). The intervention will include 12 weeks of Facebook-based messages and activities tailored to participants' stage of change.
Assessments will occur at baseline, 3, 6, and 12 months follow-up. Assessments will include measures on smoking patterns and thoughts about abstinence. All participants who report no past 7-day smoking will be asked to give biochemical verification of smoking status with saliva cotinine test kits that will be mailed to participants.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||501 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Social Media Intervention for Young Adult Smokers|
|Study Start Date :||October 2014|
|Primary Completion Date :||November 2016|
|Study Completion Date :||November 2016|
Experimental: Facebook intervention
Assignment to private group on Facebook with 3 months of content delivered to the group.
Behavioral: Facebook intervention
90 days of Facebook messaging, weekly Ask the Doctor sessions
Active Comparator: Referral
Referral to smokefree.gov website
referral to the NCI Smokefree.gov website
- 7-day point prevalence abstinence at 3 months [ Time Frame: 3 months post baseline ]Reports of no smoking in the 7 days prior to the 3 month assessment. Biochemical verification of abstinence will also be recorded.
- 7-day point prevalence abstinence at 6 months [ Time Frame: 6 months post baseline ]Reports of no smoking in the 7 days prior to the 6 month assessment. Biochemical verification of abstinence will also be recorded.
- 7-day point prevalence abstinence at 12 months [ Time Frame: 12 months post baseline ]Reports of no smoking in the 7 days prior to the 12 month assessment. Biochemical verification of abstinence will also be recorded.
- Reduction in cigarettes smoked by at least 50% between Baseline and each follow-up timepoint [ Time Frame: 3, 6, and 12 months post baseline ]Reduction will be assessed at 3, 6, and 12 month follow-ups.
- Quit attempts [ Time Frame: 3, 6, and 12 month post-baseline ]Quit attempt during the follow-up period at 3, 6, and 12 months post-baseline.
- Health risk behaviors [ Time Frame: 3, 6, and 12 months post baseline ]We will assess prevalence rates of health risk behaviors other than smoking including recent alcohol and illicit drug use, poor sleep quality, sedentary behavior, poor diet, depression, and high risk sexual behavior.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02207036
|United States, California|
|University of California San Francisco Department of Psychiatry|
|San Francisco, California, United States, 94143|
|Principal Investigator:||Danielle A Ramo, PhD||University of California, San Francisco|